Advanced Flower Capital (AFCG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for May 28, 2026, with voting available online or virtually until May 27, 2026, 11:59 PM ET.
Shareholders are encouraged to review proxy materials and annual report before voting.
Voting matters and shareholder proposals
Election of two directors: Alexander C. Frank and Marnie Sudnow, both recommended by the board.
Ratification of CohnReznick LLP as independent registered public accounting firm for the year ending December 31, 2026.
Board of directors and corporate governance
Board recommends both director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Advanced Flower Capital
- Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 20267 May 2026 - BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCGQ4 202527 Apr 2026
- Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCGInvestor presentation24 Apr 2026
- Board recommends director elections and auditor ratification, with strong governance and oversight.AFCGProxy filing17 Apr 2026
- Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCGQ2 202510 Mar 2026
- Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCGQ2 20242 Feb 2026
- Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCGQ3 202414 Jan 2026
- Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCGQ4 202424 Dec 2025
- REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCGRegistration Filing16 Dec 2025